Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=koni20 OncoImmunology ISSN: (Print) 2162-402X (Online) Journal homepage: https://www.tandfonline.com/loi/koni20 Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment Chiara Riganti, Marcello Francesco Lingua, Iris Chiara Salaroglio, Chiara Falcomatà, Luisella Righi, Deborah Morena, Francesca Picca, Daniele Oddo, Joanna Kopecka, Monica Pradotto, Roberta Libener, Sara Orecchia, Paolo Bironzo, Valentina Comunanza, Federico Bussolino, Silvia Novello, Giorgio Vittorio Scagliotti, Federica Di Nicolantonio & Riccardo Taulli To cite this article: Chiara Riganti, Marcello Francesco Lingua, Iris Chiara Salaroglio, Chiara Falcomatà, Luisella Righi, Deborah Morena, Francesca Picca, Daniele Oddo, Joanna Kopecka, Monica Pradotto, Roberta Libener, Sara Orecchia, Paolo Bironzo, Valentina Comunanza, Federico Bussolino, Silvia Novello, Giorgio Vittorio Scagliotti, Federica Di Nicolantonio & Riccardo Taulli (2018) Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment, OncoImmunology, 7:3, e1398874, DOI: 10.1080/2162402X.2017.1398874 To link to this article: https://doi.org/10.1080/2162402X.2017.1398874 View supplementary material Accepted author version posted online: 02 Nov 2017. Published online: 27 Nov 2017. Submit your article to this journal Article views: 393 View Crossmark data Citing articles: 4 View citing articles